Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri P Mikhailidis

Showing results (311-320 of 675) with videos related to

Pageof 68
Sort By:
Current Drug Targets|April 10, 2009
Triglycerides and vascular risk: insights from epidemiological data and interventional studiesKonstantinos Tziomalos, Vasilios G Athyros, Asterios Karagiannis, et al.
Annals of Medicine|April 12, 2011
Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?Vasilios G Athyros, Konstantinos Tziomalos, Georgios N Daskalopoulos, et al.
Atherosclerosis|October 9, 2015
Endocan: A novel inflammatory indicator in cardiovascular disease?Sevket Balta, Dimitri P Mikhailidis, Sait Demirkol, et al.
Current Vascular Pharmacology|February 7, 2024
Effect of Intermittent Fasting on Lipid Profile, Anthropometric and Hepatic Markers in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic ReviewMaría Fernanda Castillo, Daniela Salgado-Canales, Marco Arrese, et al.
Journal of Diabetes and Its Complications|June 6, 2020
Weight-centric pharmacological management of type 2 diabetes mellitus - An essential component of cardiovascular disease preventionEmir Muzurović, Siniša Dragnić, Sanja Medenica, et al.
Expert Opinion on Pharmacotherapy|March 10, 2010
Impact of managing atherogenic dyslipidemia on cardiovascular outcome across different stages of diabetic nephropathyVasilios G Athyros, Eydoxia K Mitsiou, Konstantinos Tziomalos, et al.
Expert Opinion on Pharmacotherapy|March 23, 2007
Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?Vasilios G Athyros, Dimitri P Mikhailidis, Anna I Kakafika, et al.
The Open Cardiovascular Medicine Journal|March 22, 2012
Gender and Socio-economic Differences in Daily Smoking and Smoking Cessation Among Adult Residents in a Greek Rural AreaEvangelia Birmpili, Niki Katsiki, Aseem Malhotra, et al.
Expert Opinion on Pharmacotherapy|April 27, 2011
What should be the optimal levels of blood pressure: Does the J-curve phenomenon really exist?Maciej Banach, Marta Michalska, Sverre E Kjeldsen, et al.
Current Medical Research and Opinion|June 27, 2009
Role and significance of statins in the treatment of hypertensive patientsMariusz Stepien, Maciej Banach, Dimitri P Mikhailidis, et al.
Pageof 68

Showing results (311-320 of 675) with videos related to

Sort By:
Pageof 68
Current Drug Targets|April 10, 2009
Triglycerides and vascular risk: insights from epidemiological data and interventional studiesKonstantinos Tziomalos, Vasilios G Athyros, Asterios Karagiannis, et al.
Annals of Medicine|April 12, 2011
Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?Vasilios G Athyros, Konstantinos Tziomalos, Georgios N Daskalopoulos, et al.
Atherosclerosis|October 9, 2015
Endocan: A novel inflammatory indicator in cardiovascular disease?Sevket Balta, Dimitri P Mikhailidis, Sait Demirkol, et al.
Current Vascular Pharmacology|February 7, 2024
Effect of Intermittent Fasting on Lipid Profile, Anthropometric and Hepatic Markers in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic ReviewMaría Fernanda Castillo, Daniela Salgado-Canales, Marco Arrese, et al.
Journal of Diabetes and Its Complications|June 6, 2020
Weight-centric pharmacological management of type 2 diabetes mellitus - An essential component of cardiovascular disease preventionEmir Muzurović, Siniša Dragnić, Sanja Medenica, et al.
Expert Opinion on Pharmacotherapy|March 10, 2010
Impact of managing atherogenic dyslipidemia on cardiovascular outcome across different stages of diabetic nephropathyVasilios G Athyros, Eydoxia K Mitsiou, Konstantinos Tziomalos, et al.
Expert Opinion on Pharmacotherapy|March 23, 2007
Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?Vasilios G Athyros, Dimitri P Mikhailidis, Anna I Kakafika, et al.
The Open Cardiovascular Medicine Journal|March 22, 2012
Gender and Socio-economic Differences in Daily Smoking and Smoking Cessation Among Adult Residents in a Greek Rural AreaEvangelia Birmpili, Niki Katsiki, Aseem Malhotra, et al.
Expert Opinion on Pharmacotherapy|April 27, 2011
What should be the optimal levels of blood pressure: Does the J-curve phenomenon really exist?Maciej Banach, Marta Michalska, Sverre E Kjeldsen, et al.
Current Medical Research and Opinion|June 27, 2009
Role and significance of statins in the treatment of hypertensive patientsMariusz Stepien, Maciej Banach, Dimitri P Mikhailidis, et al.
Pageof 68